5 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 12 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 5, Unknown 3, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 5 | Completed 3, Recruiting 1, Unknown 1 |
Follow Interstitial Cystitis: new trials by email Literature Review of Interstitial Cystitis trials Research Report on Interstitial Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome Venlafaxine oral tablet combined with Education and Behavioral Modification Program (EBMP), Education and Behavioral Modification Program (EBMP) only - Bladder Pain Syndrome, Chronic Pelvic Nociplastic Pain | Phase 1 | Not yet recruiting | Beijing Tiantan Hospital | 140 | 2026-12-31 | 2026-07-13 |
| Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome Peppermint oil, Coconut Oil - Interstitial Cystitis | Phase 1 / Phase 2 | Recruiting | University of Louisville | 100 | 2021-09-15 | 2022-08-22 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis AlloRx - Erectile Dysfunction, Peyronie's Disease | Phase 1 | Terminated | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2021-09-12 | 2026-10-20 |
| The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC) Cannabidiol vaginal suppository, Placebo vaginal suppository - Interstitial Cystitis, Bladder Pain Syndrome | Phase 1 | Withdrawn | University of New Mexico | 2021-01-01 | 2021-01-15 | |
| Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis MR-MC-01 - Interstitial Cystitis, Stem Cell Transplant | Phase 1 | Unknown | Asan Medical Center | 3 | 2020-10-20 | 2020-10-30 |
| PK and Safety of SI-722 in IC/BPS SI-722, Placebo - Interstitial Cystitis, Bladder Pain Syndrome | Phase 1 / Phase 2 | Completed | Seikagaku Corporation | 33 | 2020-03-30 | 2023-12-29 |
| Platelet Enriched Plasma for Treatment of Interstitial Cystitis platelet enriched plasma - Interstitial Cystitis, Bladder Pain Syndrome | Phase 1 / Phase 2 | Unknown | Mansoura University | 33 | 2019-03-20 | 2019-10-08 |
| Platelet-Rich Plasma (PRP) Injection in Treatment of Interstitial Cystitis Platelet-Rich Plasma - Interstitial Cystitis | Phase 1 | Unknown | Buddhist Tzu Chi General Hospital | 30 | 2017-04-01 | 2017-04-07 |
| Efficacy and Safety of Intravesical Instillations of Botulinum Toxin in TC-3 Gel in IC Patients TC-3 Gel mixed with Botox (BTX) - Interstitial Cystitis, IC | Phase 1 / Phase 2 | Completed | UroGen Pharma Ltd. | 15 | 2013-11-01 | 2016-04-12 |
| Safety Study of Single Intravesical Doses of TTI-1612 in Women With Interstitial Cystitis/Bladder Pain Syndrome TTI-1612 - Interstitial Cystitis | Phase 1 | Completed | Trillium Therapeutics Inc. | 28 | 2012-03-01 | 2013-06-26 |
| Safety Study of LiRIS in Interstitial Cystitis (IC) Patients LiRIS low dose and LiRIS high dose - Interstitial Cystitis | Phase 1 | Completed | Allergan | 18 | 2010-07-01 | 2014-11-25 |
| Phase I/II Randomized, Placebo-Controlled Study of Capsaicin for Interstitial Cystitis and Vulvar Vestibulitis capsaicin, Placebo - Interstitial Cystitis, Vulvar Diseases | Phase 1 / Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 139 | 1995-06-01 | 2025-05-04 |
Cystitis, Interstitial (12) · Cystitis (1) · Erectile Dysfunction (1) · Nocturia (1) · Pain (1) · Penile Induration (1) · Rare Diseases (1) · Urogenital Diseases (1) · Vulvar Diseases (1) · Vulvar Vestibulitis (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Male Urogenital Diseases (12) · Urinary Bladder Diseases (12) · Urologic Diseases (12) · Cystitis (11) · Urogenital Diseases (11) · Genital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Connective Tissue Diseases (1) · Disease Attributes (1) · Genital Diseases, Female (1) · Genital Diseases, Male (1) · Lower Urinary Tract Symptoms (1) · Mental Disorders (1)
Capsaicin (1) · Coconut Oil (1) · Educational Status (1) · Single Person (1) · peppermint oil (1)
Allergan (1) · Asan Medical Center (1) · Beijing Tiantan Hospital (1) · Buddhist Tzu Chi General Hospital (1) · Mansoura University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Seikagaku Corporation (1) · The Foundation for Orthopaedics and Regenerative Medicine (1) · Trillium Therapeutics Inc. (1) · University of Louisville (1) · University of New Mexico (1) · UroGen Pharma Ltd. (1)
United States (4) · Canada (2) · Antigua and Barbuda (1) · Egypt (1) · Israel (1) · South Korea (1) · Taiwan (1)
Ahmed El Hefnawy, Msc, MD (1) · Amnon Zisman, MD (1) · Chadwick Prodromos, MD (1) · Curtis Nickel, MD (1) · Gena Dunivan, M.D. (1) · Hugh Flood (1) · Myung-Soo Choo, M.D, Ph.D (1) · Penka Petrova, PhD (1) · Sean Francis, MD (1)
R01DK049524 (1)